AntigenApp: a laboratory data management system for nanobody generation and sequence analysis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41325195.
- Also identified by DOI 10.1093/bioinformatics/btaf642 and PMC identifier 12701793.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nanobodies are single domain antibodies derived from the unique heavy chain-only immunoglobulins of the camelid family, and have broad applications in biosciences, including as imaging and diagnostic agents. The generation of nanobodies is a multi-stage experimental process for which we have developed AntigenApp a laboratory data management system for nanobody generation and sequence analysis. AntigenApp is a web application and database built to capture data generated during all steps of the nanobody discovery pipeline and to provide built-in analysis capabilities of the experimental results. This includes enzyme-linked immunosorbent assay optical density measurements, sequencing results, nanobody domain labelling, and search/clustering capabilities using protein BLAST. The tool incorporates a standardized naming convention that is automatically applied to nanobodies stored in the database and we envisage the tool being of interest to the wider nanobody community for in-house use. AntigenApp is available from https://github.com/rosalindfranklininstitute/antigen-app under the Apache 2.0 licence and published https://doi.org/10.5281/zenodo.17397055.
Medical subject headings
- Single-Domain Antibodies
- Software
- Sequence Analysis, Protein
- Database Management Systems